Alanylglutamine Composition for Concentration Enhancement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current compositions do not effectively enhance the ability to concentrate, which is crucial for mental focusing and processing stimuli during activities like learning and sports.
Innovation Solution
A composition containing alanylglutamine or its salt as an active ingredient, administered through various pharmaceutical preparations, including oral and parenteral forms, to improve mental focusing and attention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If alanylglutamine is used as a glutamine supply source in parenteral nutritional agents, then heat stability and solubility are improved, but the ability to enhance concentration is not achieved
Solution Approach 1:
The patent applies parameter changes by optimizing the concentration of alanylglutamine in the composition (0.1-100% by weight, preferably 0.5-70% by weight, particularly preferably 1-50% by weight) to achieve both stability and concentration enhancement effects. This quantitative parameter optimization resolves the contradiction between maintaining stability and achieving the desired physiological effect.
2Quantity of substance
If alanylglutamine is used as a glutamine supply source in parenteral nutritional agents, then solubility in aqueous solutions is improved, but the ability to enhance concentration is not achieved
Solution Approach 1:
The patent utilizes parameter changes by controlling the concentration range of alanylglutamine (0.1-100% by weight, preferably 0.5-70% by weight, particularly preferably 1-50% by weight) to simultaneously achieve high solubility in aqueous solutions and the physiological effect of enhancing concentration ability, thus resolving the contradiction between solubility and functional efficacy.
3Ease of manufacture
If conventional compositions are used, then manufacturing simplicity is maintained, but the ability to enhance concentration is not achieved
Solution Approach 1:
The patent applies parameter changes by specifying precise concentration ranges for alanylglutamine (0.1-100% by weight, preferably 0.5-70% by weight, particularly preferably 1-50% by weight) that can be easily incorporated into existing manufacturing processes, thereby achieving concentration enhancement without significantly complicating manufacturing procedures.
Data Source
AI summary
A composition for enhancement of ability to concentrate and method of improving ability to concentrate using alanylglutamine or a salt of alanylglutamine as an active ingredient.